Industry Leader in Biotechnology Research, Gene Bio Medical Helps Create a Path to the Future of Innovation in Health.
Biotechnology research company, Gene Bio Medical participated as a VIP Sponsor at the 22nd Annual Healthcare Summit September 22 & 23, 2022 in Vancouver, BC. The summit attracted leaders, innovators & educators. The top tier national and international decision makers in healthcare policy and administration. The event brought people together to connect, educate and discuss new strategies that will drive innovation for future implementation of transformative healthcare. The theme around this year’s summit: The Future of Innovation, Personalized Medicine and Genomics.
Gene Bio Medical sponsored the 22nd Annual Healthcare Summit because they understand the importance of creating space for discussions, education and strategic planning for the transformation of the healthcare system into data, digital and Artificial Intelligence.
Geno Bio Medical is an industry leader in research, development and manufacturing. Known for rapid diagnostics, molecular diagnostics and diagnostic devices and instruments.
Focusing on developing, manufacturing and research allows Gene Bio Medical to bring new technologies to healthcare providers and consumers, help innovators manufacture, develop and create which brings solutions to the industry and community at large for various healthcare needs.
The summit opened with discussions on how the pandemic shinned a light on the weak spots in Canada’s health system. And revealed how vulnerable the healthcare industry is to change and its need for structural and technological transformation. This led to discussions about cyber security, data transforming, employee retention, patient care, ethics, manufacturing, collaboration, innovation and the merge of information.
Keynotes, moderators and panellists brought health innovation and action items to the fore front of the healthcare industry.
“Gene Bio Medical is proud to sponsor & support such an important event along side all the other sponsors who made this event possible. The Summit was full of remarkable industry leaders, great discussions, education and opportunities for the future of the whole health industry. Gene Bio Medical is excited to be a part of the changing healthcare system.”
Brent A. Reynolds, PhD, received his Ph.D. in 1994 from the University of Calgary during which time he and Sam Weiss discovered the existence of a stem cell in the adult central nervous system, challenging a century old dogma that the adult brain was unable to produce new neurons. He co-founded NeuroSpheres Ltd. where he was Vice-President of Research and in 1999 published the first report on the trans-differentiation of cells derived from one germ layer into functional cells of another germ layer.
Professor Reynolds holds 16 US patents related to neural stem cells and his lab is currently focused on the development of stem cell specific assays, in situ manipulation of neural stem cells and understanding the role that solid tissue cancer stem cells play in tumor initiation and metastasis.
Professor Reynolds, is CSO of Gene Bio Medical and is excited about the future of manufacturing, creating new medical devices, enhancing the transformation of the healthcare system and collaborating with industry partners. “Anything is possible.”
Leading the Way in Innovative Healthcare Research, Development & Manufacturing.
Gene Bio Medical Merges & Acquires Canadian Phytopharmaceuticals Corporation.
Canadian Phytopharmaceuticals Corp. (CPC) is a fully integrated cGMP contract manufacturer of herbal extracts, dietary supplements, vitamins and minerals, and natural health products.
They proudly provide customers with advanced research, development and manufacturing services supported by their state-of-the-art manufacturing facilities and highly experienced team of scientists and experts.
Their deep roots in scientific innovation have established them as the premier organization in providing top quality natural health products formulated with the ever-evolving technology of the 21st century.
“We are very excited about merging and acquiring CPC. This will expand our manufacturing, development capacity, and create more opportunities for Gene Bio Medical, CPC and industry partners. Along with building a stronger research, manufacturing and development sector for the health industry.”
– Gene Bio Medical
Connecting with Healthcare Leaders & Innovators: Healthcare Summit 2022
Gene Bio Medical was the VIP Sponsor of the Reception held after the first day of the Summit was complete. The reception was held at the Treehouse Restaurant in Stanley Park, Vancouver BC. It was a beautiful venue & perfect evening, filled with inspirational conversations, networking between industry leaders and an opportunity to talk about moving the health care system into the transformational digital age.
Healthcare Innovation will benefit the entire society, industry and collaborating industries & partners.
– Let’s embrace change.
Healthcare Innovation will benefit the entire society, industry and collaborating industries & partners.
– Let’s embrace change.
Event Highlights: Day 1
Dr Alan low, (Clinical Associate Professor, Faculty of Pharmaceutical Sciences, UBC; Exec. Director, MedAccess BC; Primary Care Pharmacist & Pharmacy Lead, BioPro Biologics Pharmacy) played a key role in the 2022 Health Care Summit. Opening the summit each day with the Territorial Acknowledgement. Along with closing remarks on both days.
André Picard: A veteran health reporter with the Globe and Mail provided a top 5 “to-do” list for reforming Medicare, in his Keynote about Rebooting Medicare: A post-pandemic prescription for reviving a faltering Health system.
Everyday people are watching innovation transform multiple industries.
The Honourable Fred Horne (Former Alberta Minister of Health; Senior Advisor, 3Sixty Public Affairs); Sue Paish (CEO, Digital Supercluster); Dr. Ian Rongve, (Assistant Deputy Minister, Strategy & Innovation Division, Ministry of Health, Province of BC), and Kim Wieringa (Assistant Deputy Minister, Alberta Health, Health Information Systems Division, Government of Alberta) joined together on a panel Moderated by Moderator: Dr. Alan Low, (Clinical Associate Professor, Faculty of Pharmaceutical Sciences, UBC; Exec. Director, MedAccess BC; Primary Care Pharmacist & Pharmacy Lead, BioPro Biologics Pharmacy), to discuss: If innovation will transcend healthcare’s traditional boundaries. Focusing on how existing health systems from treatment-based reactionary care to prevention and well-being need to work collectively for the heath system to transform. They discussed six key areas needed to make the transformation: data sharing, interoperability, equitable access, empowered consumers, behaviour change, and scientific breakthrough.
Dr. Indra Joshi (Health, Research & AI Strategist, Palantir Technologies) and Harjeet Dhaliwal, (Deployment Strategist, Palantir Technologies) discussed data, digital and AI transformation and impact of frontline care delivery and system optimization. They shared how the UK healthcare system accelerated their digital journey, connecting the system through a common data platform and enabled cutting-edge AI technologies. And the importance of implemented data and AI while utilizing it in a safe and ethical way.
Mary Ackenhusen, (Senior Healthcare Executive; Executive Advisor, Deloitte), moderated a panel based around the recent global report by Elsevier and Ipsos entitled “Clinician of the Future”, which tells us that one in three clinicians are considering leaving their current role by 2024. Dr. Matthew Chow. (Executive Medical Director Mental Health, TELUS Health), Lisa Chu, (Dean, School of Health Sciences, BCIT) Dr. Celia Richardson, (Senior Principal, Innovation & Thought Leadership – Talent & Organization, Accenture) and Christine Sorensen (Former President, BC Nurses’ Union) discussed how healthcare stakeholders will need to reimagine how they support current workers as well as
evolve the systems and mindset to create an effective workforce for the future. Traditional tools such as recruitment, increased education capacity, and retention are still critical, to ensure the sustainability of a high-quality healthcare system, but it will be important to redesign systems, labour substitution and leveraging the power of technology and analytics going forward. Innovation in the Laboratory Space and Implementing In-house CGP was presented by Dr. Faisal Khan, (Co-founder & CEO, OncoHelix). He stated there is value for Canadian health care providers and their patients in moving from multi-gene panels to CGP within Canadian Labs for Research and for Clinical Care.
Microsoft Keynotes Ali Mussavi, (Executive Director for Data Architecture and Governance, Provincial Health Services Authority) and Dr. Helia Mohammadi, (Chief Data Scientist and Healthcare Industry Lead, Microsoft Canada) discussed the importance of Driving Healthcare Innovation with data analytics & technology intrapreneurship with PHSA and how a successful data analytics strategy must consider cultural, business, technological and ethical issues all while meeting a challenging climate of Canadian regulation and system complexity.
With the recent development and refinement of digital health technologies, offering timely and appropriate health services to patients at their own homes are increasingly abundant and sophisticated.
Moderator: Dr. Kendall Ho, (Emergency Physician; Professor, UBC Faculty of Medicine, Department of Emergency Medicine), explored the current state-of-the-art approaches in digital health for providing point of care services where the patients are, and what the future holds in this health service transformation enabled by digital technologies with panelists: Susan Anderson, (Chief Information Officer, Nunavut Department of Health), David Helliwell, (Co-Founder & Executive Board Chair, Thrive Health) and Matthew Lehner CTO, OneFeather)
“Trust but Verify”: Patient Trust & Information Integrity Through Privacy & Security.
Moderator: Drew McArthur, (Principal, The McArthur Consulting Group), Joined by panellists: Jaime Chanagá, (Field Chief Information Security Officer (CISO), Fortinet), Quinn Mah, (Executive Director – Information Management, Alberta Health), Pamela Snively, (VP, Chief Data & Trust Officer, TELUS), informed that it is imperative for cybersecurity and privacy to become fully integrated,
by design, in the piloting and deployment of healthcare services and solutions.
Care providers are finding it increasingly difficult to operate businesses, implement technology solutions and provide care. Hamed Shahbazi, (Chairman and CEO, WELL Health) talked about how we can solve these challenges by leveraging technology, scale and sound business practices.
Joel Mueller, (Group Manager – Technical Competitive Intelligence, Okta), and Adam Crown, (Group Product Marketing Manager, Healthcare Solutions, Okta) bring forward how health systems across the country are facing staff shortages and employee burnout. Patients are suffering from gaps in care due to wait times and how technology is key to shifting the paradigm from reactive to proactive.
Rich Birhanzel, Global Health Lead, Accenture, discuss the importance of the “Metaverse Continuum” a spectrum of digitally enhanced worlds, realities and business models is poised to revolutionize life and enterprise in the next decade.
Event Highlights: Day 2
Professor George Crooks, (Chief Executive Officer, Digital Health & Care Innovation Centre (Scotland)) challenged our thinking about the current healthcare delivery models. In his fireside chat with Moderator: John Matheson, (Consultant, Digital Health and Innovation Centre, University of Strathclyde; Board Member, Doctors and Dentists Review Board; Consultant, CGI; Chair, Audit and Risk Committee, Transport Scotland). Professor Crook explored the challenges being experienced by health and care systems around the world and showcased how it is possible through intelligent use of next generation digital tools and services to provide high quality, safe, effective and sustainable healthcare for our citizens.
Healthcare, Innovation & Collaboration are the key to making the healthcare system work for everyone.
Moderator: John Jacobson; Former Deputy Minister, Ministry of Technology, Innovation and Citizens’ Services), led an open conversation where panelist shared their perspectives on the ongoing and urgent need for sustained innovation to deal with the remaining obstacles that bog down healthcare delivery. And where the other panelists will share their perspectives on how privacy-conscious technologies can provide a direct and powerful response to healthcare’s need for speed. With panelists: Dr. Fiona Duncan, (Physician Lead, Vancouver Division of Family Practice; Clinical Assistant Professor, Department of Family Practice, UBC), Sarah Hamilton, (Patient Advisor, Patient Voices Network), Dr. Holly Longstaff,
(Director Research Integration and Innovation, Provincial Health Services Authority (PHSA)), Joerg Schwarz, (Senior Director, Strategy and Solutions, Healthcare Interoperability, Infor.
Moderator: Tara McCarville, (Principal Consultant, Brighton Group; Board Member, Starling Minds and WELL Health) Joined by panelists; Dr. Pieter Cullis, (Scientific Director and CEO, NanoMedicines Innovation Network; Professor, Department of Biochemistry & Molecular Biology, UBC), Dr. Paul Krzyzanowski, (Medical Director, Precision Medicine, Janssen Canada), Dr. Samantha Pollard, (Senior Methodologist, Cancer Control Research, BC Cancer) explored challenges and successes in bringing precision medicine with patient access to innovative diagnostics and targeted therapeutics this vision to life – from R&D to diagnostics to analytics to treatments – and the impacts on patient outcomes and health system utilization.
Moderator: Dianne Balon, (Vice President, Government, Alberta Blue Cross) hosted: Thomas O’Shaughnessy, (Partner and Leader, Health Care (Western Canada), Deloitte), Wes Sylvester, (WW Vice President, Industry Solutions Group, Cisco), Jeremy Mickolwin,(VP, Clinic Operations, WELL Health), Dr. Joby McKenzie, (Managing Director, Canada, Teladoc Health) in a discussion that explored what Canada needs to do right now to address the challenges being faced by the primary care crisis. Looking at innovation and digital technology to offer some new ways of improving access to care and strengthening the primary care system.
The World Health Organization (WHO) has declared antibiotic resistance as “one of the biggest threats to global health, food security, and development today”. It is estimated that over 1.2 million deaths were caused by antibiotic-resistant bacterial infections globally in 2019.
Moderator: Dr. Sameeh Salama, (Chief Scientific Officer, Fedora Pharmaceuticals), and panelists: Emily Beduz, (Manager, Federal Affairs and Public Policy, GSK), Dr. John Conly, (Professor of Medicine, University of Calgary; Medical Director, W21C), Dani Peters, (Senior Advisor, Canadian Antimicrobial Innovation Coalition (CAIC); President, Magnet Strategy Group), Joan Weir, (Vice President, Group Benefits, Canadian Life and Health Insurance Association) discussed the urgent need for new antibiotics and the barriers that have led to low access to such lifesaving antibiotics in Canada along with mechanisms to reverse this trend.
Dr. Eman Hassan, (Executive Director, BC Centre for Palliative Care) and Kevin Harter, (Chief Executive Officer, Victoria Hospice), identified not only the current challenges but the strategic ‘Path Forward’ in an initiative undertaken collaboratively by five leading hospice palliative care organizations in BC to address that the system today must find a way to pivot to accommodate the needs of those approaching end-of-life and explore innovative solutions to alleviate the burden on our health care system.
Stephen Goldsmith, (BA; Mireille Luc, PhD VP, Business Development, Petal Solutions) Explained how The Petal Orchestrator is a Cloud-Based digital platform that provides the most critical assets but more specifically output visualization of patient needs, workforce capacity, and their ‘human fit’ data. Petal Orchestrator takes advantage of the synergetic effect of the Quintuple Aim and unlocks the potential for high-performing healthcare systems through better access.
How is the Personalized Medicine Revolution Going to Evolve? A question leaders and innovators are working on together to transform the Health System to the Digital era.
Dr. Pieter Cullis, (Professor, Biochemistry and Molecular Biology, UBC) talked about how medicine is going to undergo a profound change as we transition from reactive, one-size-fits all medicine to preventive, personalized medicine.
Moderator: Suzanne Gill, (President & CEO, Genome BC) led a discussion around how the role of genomics in precision health became more evident since the COVID-19 pandemic. While discussing innovations that can be brought in to provide high quality and equitable genomics education to health providers across professions to benefit patients. The panel of experts will share their knowledge, experience, and enthusiasm on GEHP (Targeted Genomics Education for Health Professionals) Panellists: Sarah Dewell, (Assistant Professor, School of Nursing, UNBC), Dr. Anna Lehman, (Clinical Geneticist, BC Children’s and BC Women’s Hospital; Associate Professor, Department of Medical Genetics, UBC), Dr. Catalina Lopez-Correa, (Chief Scientific Officer, Genome Canada), Glynda Rees, (Program Lead Digital Health Advanced Certificate, BCIT; Faculty, Bachelor of Science Nursing Program, BCIT).
What is the future of digital health? A big question which requires a step back to think through some fundamental questions.
Panellists: Jimmy Yang, (Managing Director, Canada Health Industry Lead, Accenture), Dr. Alina Turner, (Co-Founder & Co-President, HelpSeeker Technologies), Allie DeLonay, (Data Scientist, Data Ethics Practice, SAS) with Moderator: Dr. Chris Eagle, (Board Chair, Alberta Cancer Foundation) discuss ethics (particularly equity) and how Canada’s rich diversity of culture, ethnicity, gender identification, wealth, education, language, and religious beliefs challenges our ability to find common answers but may enable very robust solutions.
Closing Panel: Where the Rubber Hits the Road: Implementing Innovation Now
Canada’s universal healthcare system is exhausting. Health innovations needs to be put to the practical test of implementation: “the rubber needs to hit the road”.
Moderator: Dr. Robert Fraser, (President and CEO, Molecular You), host panelist: Thea Discepola, (Vice President, Value Access & New Product Planning, Novartis Pharmaceuticals), Craig Ivany, (Chief Provincial Diagnostics Officer, Provincial Health Services Authority), Dr. Evgueni Loukipoudis, (Chief Technology Officer, Circle Innovation), Tim Murphy; (Vice President, Health, Alberta Innovates), Dr. Durhane Wong-Rieger, (President & CEO, Canadian Organization for Rare Disorders to highlight the key points and takeaways from the summit proceedings. In discussion with the audience the panel proposed near-term actions that will benefit from the innovation inertia of the COVID-19 pandemic to build an equal access system of disease prevention, personalized medicine and healthy longevity.
For more information on the Healthcare Summit visit here:
Reboot Communications | 22nd Annual Healthcare Summit – Reboot Communications
NEW: Gene Bio Medical merged & acquired Canadian Phytopharmaceuticals Corporation, a medical manufacture in Richmond BC: https://canphyto.com/
